AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Enveda raises $311 million in Series E funding led by Catalio Capital Management to advance its AI-driven drug discovery efforts.
PRIVATESep 23, 2026•about 4 hours ago
Amount Raised
$311 Million
Round Type
Series E
BoulderBiotechnology
Investors
Alderline GroupSovereign Wealth FundDigitalis VenturesT. Rowe Price Investment ManagementSurveyor CapitalLightspeedIconiqDurable Capital PartnersCatalio Capital Management
Description
Enveda, a clinical-stage biotechnology company, has closed a $311 million Series E financing round. The round was led by Catalio Capital Management and included investments from various prominent investors. The funding will be used to enhance the company's ability to discover medicines using AI technology. This significant capital injection marks a key milestone in Enveda's journey to revolutionize pharmaceuticals.
Company Information
Company
Enveda
Location
Boulder, Colorado, United States
About
Enveda is a biotechnology company that is learning from life’s chemistry to create better medicines faster. Enveda uses AI-powered tools to identify and characterize a wide range of molecules produced by living organisms—the vast majority of which have never been explored by science—creating a database of chemical biodiversity: the library of life. By growing, organizing, translating, and searching this unique library, Enveda learns from life’s evolved solutions to address today’s pressing medical needs.
Fundz sees it the moment Enveda raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
BoulderBiotechnology